Compliance & Legal

Impacted payers need to send prior authorization decisions within 72 hours for urgent requests and seven days for standard requests.

The New Jersey health system's CIDO Sunil Dadlan explains how his teams have worked to implement effective and ethical AI, and offers perspective on challenges around regulations, workforce and interoperability.

EHRA, HIMSS and others cite regulatory variability and redundancy, as well as costs, as roadblocks to interoperable health information exchange, while ACR stresses investigatory protections for physicians.

Rachini Moosavi, chief analytics officer at University of North Carolina Health, describes how and where AI is deployed at the health system – and says it plans to be ambitious in its deployments in 2024 while still being cautious.

The American Hospital Association questions the agency's calculations, and said the proposed information blocking penalties could threaten the financial viability of many small and rural hospitals.

With guidelines and rules for healthcare AI coming from the FDA, ONC, OCR, the White House and others, how will this regulatory framework change in 2024? Bryant Godfrey, partner at Foley Hoag, offers some thoughts.  

The agency says it has seized thousands of units of the product, which has crept its way into the legitimate U.S. drug supply chain.

For all its potential benefits for healthcare, it's still critical to understand how patient data is being collected and used for AI models, says Sara Shanti, a partner in Sheppard Mullin's Chicago-based Corporate Practice Group.

The Medical Group Management Association says ONC's proposed rules add undue financial burden to practices and would affect the delivery of Medicare and value-based care.

Andreessen Horowitz investment partner Jay Rughani discusses the paper he and his colleagues published recently about clinical use cases of AI, and outlined steps regulators should take for reimbursing providers using the technology.